Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

Blood (2016) 128 (22): 4314.

https://doi.org/10.1182/blood.V128.22.4314.4314

Published: 2016

Journal Articles

HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Justin Kaner, MD, Santiago Thibaud, MD, Ashwin Sridharan, MD, Amer Assal, MD, Rahul Polineni, MD, Barry Zingman, MD, Anjali Sharma, MD, Harold Kunal Elias, MD, Louis Weiss, MD MPH, Murali Janakiram, MD, Ira Braunschweig, MD, Swati Goel, MD, Ulrich Steidl, MDPhD, Kith Pradhan, PhD, Aditi Shastri, MD, Britta Will, PhD, Ioannis Mantzaris, MD, Mark Chaitowitz, MD, Amit Verma, MD

Blood (2016) 128 (22): 4345.

https://doi.org/10.1182/blood.V128.22.4345.4345

Published: 2016

Journal Articles

Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia

Britta Will, PhD, Thomas O. Vogler, Swathi-rao Narayanagari, Boris Bartholdy, Tihomira I. Todorova, MSc, Jiahao Chen, Yiting Yu, Jillian Mayer, Mariana da Silva Ferreira, Laura Barreyro, PhD, Luis Carvajal, Michael Roth, MD, Johanna van Oers, Sonja Schaetzlein, Christine McMahon, MD, Winifried Edelmann, Amit Verma, MD, Ulrich Steidl, MDPhD

Blood (2015) 126 (23): 305.

https://doi.org/10.1182/blood.V126.23.305.305

Published: 2015

Journal Articles

New Allosteric Inhibitors of Mutant IDH1 in Acute Myeloid Leukemia

Blood (2015) 126 (23): 787.

https://doi.org/10.1182/blood.V126.23.787.787

Published: 2015

Journal Articles

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Timothy Geoffrey Bowler, PhD MBBS, Matthias Bartenstein, MD, Kerry A. Morrone, MD, Mersedeh Rohanizadegan, MD, Rachel M. Kessel, MD, Lauren Hooda, Ishan Datt, Orsolya Giricz, PhD, Tushar D. Bhagat, PhD, Bartlomiej P Przychodzen, Simrit Parmar, Jonathan B. Gill, MD, Yiting Yu, PhD, Jaroslaw P. Maciejewski, MD PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 4591.

https://doi.org/10.1182/blood.V124.21.4591.4591

Published: 2014

Journal Articles

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Aditi Shastri, MD, Carolina Schinke, MD, Asya Varshavsky Yanovsky, MD PhD, Tushar D. Bhagat, PhD, Orsolya Giricz, Laura Barreyro, M.Sc., Jacqueline Boultwood, PhD, Andrea Pellagati, Yiting Yu, PhD, Jennifer R. Brown, MD PhD, David A. Frank, MD PhD, Bhaskar Das, PhD, Suman Kambhampati, MD, Britta Will, PhD, Ulrich Steidl, MDPhD, Amit Verma, MD

Blood (2014) 124 (21): 3602.

https://doi.org/10.1182/blood.V124.21.3602.3602

Published: 2014

NARROW

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia

New Allosteric Inhibitors of Mutant IDH1 in Acute Myeloid Leukemia

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Email alerts

ASH Publications

American Society of Hematology

Targeting MDS and AML Stem Cells with AZD-9150 Mediated Inhibition of STAT3

HIV Is Associated with a High Rate of Unexplained Multilineage Cytopenias and Portends a Poor Prognosis in Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)

Minimal Reduction of PU.1 Is Sufficient to Induce a Preleukemic State and Promote Development of Acute Myeloid Leukemia

New Allosteric Inhibitors of Mutant IDH1 in Acute Myeloid Leukemia

Exome Sequencing of Familial MDS Reveals Novel Mutations and High Rates of False Positive Mutations in MLL3 Due to Pseudogene Effects

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only